Skip to main content

Mellion Michelle L

No open-market purchases or sales filed in the past year.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
–
0 filings
Net
–
Bought minus sold
Companies
0
With open-market trades

Trades

Every Form 4 that lists Mellion Michelle L as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 26, 2024 (view filing)Jul 24-252 daysMellion Michelle LChief Medical OfficerSSale−7.77K$18.06−$140.4K−100.0%0 after2 lots10b5-1
Jul 19, 2024 (view filing)Jul 181 dayMellion Michelle LChief Medical OfficerSSale−12.6K$18.20−$229.8K−100.0%0 after10b5-1
Jul 16, 2024 (view filing)Jul 12-164 daysMellion Michelle LChief Medical OfficerSSale−9.19K$18.01−$165.5K−100.0%0 after2 lots10b5-1
Jul 3, 2024 (view filing)Jul 1-22 daysMellion Michelle LChief Medical OfficerSSale−912$18.01−$16.4K−100.0%0 after2 lots10b5-1
Jun 26, 2024 (view filing)Jun 242 daysMellion Michelle LChief Medical OfficerSSale−9.26K$18.19−$168.4K−100.0%0 after10b5-1
Jun 13, 2024 (view filing)Jun 11-122 daysMellion Michelle LChief Medical OfficerSSale−1.59K$18.05−$28.6K−100.0%0 after2 lots10b5-1
Jun 7, 2024 (view filing)Jun 5-62 daysMellion Michelle LSVP, Clinical DevelopmentSSale−8.66K$18.08−$156.5K−100.0%0 after2 lots10b5-1